Nucl Med Mol Imaging.  2020 Apr;54(2):120-122. 10.1007/s13139-020-00637-8.

Renal Potassium Excretion Visualized on 82Rubidium PET/CT

Affiliations
  • 1Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, 8200 Aarhus N, Denmark
  • 2Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  • 3Department of Urology, Aarhus University Hospital, Aarhus, Denmark

Abstract

The positron emission tomography (PET) flow tracer 82Rubidium is a known potassium analogue. During our studies of tumor blood flow in prostate cancer, we found that approximately 10% of the patients had high urinary 82Rubidium activity. In roughly half of these patients, the increased renal rubidium/potassium excretion was either causing hypokalemia or explained by Thiazide treatment. In the other half, there was no obvious explanation or clinical consequence of the renal rubidium/potassium excretion. This is the first time enhanced renal potassium excretion is visualized on 82Rubidium PET/CT.

Keyword

82Rubidium; Hypokalemia; Potassium; Renal excretion; Prostate cancer; PET
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr